Occludin and Zonulin in Attention-deficit/Hyperactivity Disorder

NCT05502471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2022-08-16

No results posted yet for this study

Summary

The association between levels of zonulin and occludin and behavioral/emotional problems in children with ADHD are investigated.

Conditions

  • Attention-deficit/Hyperactivity Disorder

Interventions

DIAGNOSTIC_TEST

Zonulin

Serum zonulin level

DIAGNOSTIC_TEST

Occludin

Serum occludin level

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • Hicran Dogru, MD · Ataturk University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05502471 on ClinicalTrials.gov